Category | Variable | Participants completed the study (20): n (%) | Participants lost to follow (3): n (%) |
---|---|---|---|
Gender | Female | 14 (70%) | 2 (66.67%) |
Male | 6 (30%) | 1 (33.33%) | |
Age | 18–24 | - | - |
25–34 | - | - | |
35–44 | 6 (30%) | 2 (66.67%) | |
45–54 | 6 (30%) | 1 (33.33%) | |
55–64 | 6 (30%) | - | |
65–74 | 1 (5%) | - | |
75–84 | - | - | |
85 or older | 1 (5%) | - | |
Marital status | Single | 2 (10%) | 2 (66.67%) |
Married | 17 (85%) | 1 (33.33%) | |
Widowed | - | - | |
Divorced | 1 (5%) | - | |
Separated | - | - | |
MS type | RR MS | 12 (60%) | 2 (66.67%) |
PP MS | 5 (25%) | 1 (33.33%) | |
SP MS | 3 (15%) | - | |
PR MS | - | - | |
MS diagnosis in years | 1–5 | 2 (10%) | - |
6–10 | 8 (40%) | 1 (33.33%) | |
11–15 | 3 (15%) | 2 (66.67%) | |
16–20 | 3 (15%) | - | |
21–25 | 2 (10%) | - | |
26–30 | 1 (5%) | - | |
31–35 | - | - | |
36–40 | - | - | |
41–45 | 1 (5%) | - | |
LUTSs main | Urgency | 16 (80%) | 3 (100%) |
Frequency | 13 (65%) | 2 (66.67%) | |
Nocturia | 12 (60%) | 1 (33.33%) | |
Urge incontinence | 6 (30%) | 1 (33.33%) | |
Terminal dribbles | 4 (20%) | - | |
Hesitancy | 5 (25%) | - | |
Feeling of incomplete bladder emptying | 8 (40%) | 1 (33.33%) | |
Urinary incontinence | 5 (25%) | 2 (66.67%) | |
Double void | 4 (20%) | 1 (33.33%) | |
LUTSs in years | 1–5 | 6 (30%) | 1 (33.33%) |
6–10 | 9 (45%) | - | |
11–15 | 3 (15%) | 2 (66.67%) | |
16–20 | 1 (5%) | - | |
21–25 | 1 (5%) | - | |
Previous TX | None | 4 (20%) | 1 (33.33%) |
Pharmacologic | 7 (35%) | 1 (33.33%) | |
Non-pharmacologic: | Â | Â | |
Exercises | 3 (15%) | 1 (33.33%) | |
Nerve stimulation with another treatment (Exercise and/or Catheterization) | 3 (15%) | - | |
Behavioural | 3 (15%) | - | |
Current TX | None | 6 (30%) | 2 (66.67%) |
Pharmacologic | 9 (45%) | 1 (33.33%) | |
Pharmacologic with Catheterization | 2 (10%) | - | |
Non-pharmacologic: | |||
Exercises | 2 (10%) | - | |
Nerve stimulation | - | - | |
Behavioural | 1 (5%) | - | |
Prophylactic | Yes | 3 (15%) | - |
No | 17 (85%) | 3 (100%) | |
Comorbidities | None | 8 (40%) | 1 (33.33 %) |
Thyroid related issues | 2 (10%) | 1 (33.33%) | |
Hypertension | 1 (5%) | 1 (33.33%) | |
Reynolds syndrome | 1 (5%) | Â | |
Cancer | 1 (5%) | - | |
Foot drop/mobility | 2 (10%) | - | |
Migraine | 1 (5%) | 1 (33.33%) | |
hearing impairment | 1 (5%) | - | |
Bowel related issues/duodenal ulcer | 3 (15%) | - | |
PDDS-Mobility | (0) Normal | 3 (15%) | - |
(1) Mild disability | 1 (5%) | Â | |
(2) Moderate disability | 3 (15%) | 1 (33.33%) | |
(3) Gait disability | 2 (10%) | Â | |
(4) Early cane | 3 (15%) | Â | |
(5) Late cane | 4 (20%) | 1 (33.33%) | |
(6) Bilateral support | 3 (15%) | Â | |
(7) Wheelchair | 1 (5%) | 1 (33.33%) | |
(8) Bedridden | - | Â |